Flow cytometric analysis revealed that ssRNA and dual-function vector treatment significantly increased the proportion of pDCs (CD317+CD11c+B220+) in tumor tissues (Figure 5A) and also enhanced the expression of CD80 and CD40 on pDCs, which suggest the activation of pDCs. Here, ITGAX is linked to neoplasm.